IonQ Rallies on Quantum Computing Growth

IonQ’s stock surged in February 2026 after reporting accelerated revenue growth driven by expanded enterprise adoption of its trapped-ion quantum computing systems. The company highlighted new partnerships with Fortune 500 firms in pharmaceuticals and finance, leveraging quantum advantage for drug discovery and portfolio optimization. IonQ’s latest 32-qubit system achieved record-low error rates, positioning it ahead of competitors in the race for fault-tolerant quantum computing. Analysts attribute the rally to a $200 million Department of Defense contract for quantum cybersecurity applications, signaling government confidence in the technology. CEO Peter Chapman emphasized scalability milestones, projecting commercial viability by 2028 as hardware improvements outpace classical supercomputers in specific workloads.